Report overview
Anti-hair loss medicine are drugs used to prevent, suppress, and treat hair loss.
This report contains market size and forecasts of Anti-Hair Loss Medicine in Global, including the following market information:
Global Anti-Hair Loss Medicine Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Anti-Hair Loss Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Hair Growth Liquid Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-Hair Loss Medicine include Giuliani, Bayer AG, Regaine, Pfizer, Hims & Hers Health, Inc., Nutraceutical Wellness, Inc., Renhe Group Co., Ltd. and Bawang(Guangzhou)Co.,Ltd., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Anti-Hair Loss Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Hair Loss Medicine Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Anti-Hair Loss Medicine Market Segment Percentages, by Type, 2022 (%)
Hair Growth Liquid
Tablet
Others
Global Anti-Hair Loss Medicine Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Anti-Hair Loss Medicine Market Segment Percentages, by Application, 2022 (%)
Pharmacy
Hospital
Global Anti-Hair Loss Medicine Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Anti-Hair Loss Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Hair Loss Medicine revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-Hair Loss Medicine revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Giuliani
Bayer AG
Regaine
Pfizer
Hims & Hers Health, Inc.
Nutraceutical Wellness, Inc.
Renhe Group Co., Ltd.
Bawang(Guangzhou)Co.,Ltd.
